{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T04:12:40Z","timestamp":1784607160827,"version":"3.55.0"},"reference-count":23,"publisher":"Tsinghua University Press","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.26599\/1671-5411.2023.09.002","type":"journal-article","created":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T03:26:50Z","timestamp":1697167610000},"page":"684-692","source":"Crossref","is-referenced-by-count":5,"title":["Predictive value of bleeding risk scores in elderly patients with atrial fibrillation and oral anticoagulation"],"prefix":"10.26599","volume":"20","author":[{"given":"Pablo","family":"Dom\u00ednguez-Erquicia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Raposeiras-Roub\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emad","family":"Abu-Assi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Lizancos-Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose A","family":"Parada-Barcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9","family":"Gonz\u00e1lez-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Ledo-Pi\u00f1eiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanesa","family":"Noriega-Caro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Iglesias-Otero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9s","family":"\u00cd\u00f1iguez-Romo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"11138","reference":[{"key":"ref2","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.jacep.2015.02.019","article-title":"Age-related differences in presentation, treatment, and outcome of patients with atrial fibrillation in Europe: The EORP-AF General Pilot Registry (EURObservational Research Programme-Atrial Fibrillation)","volume":"1","author":"S Fumagalli","year":"2015","unstructured":"S Fumagalli. Age-related differences in presentation, treatment, and outcome of patients with atrial fibrillation in Europe: The EORP-AF General Pilot Registry (EURObservational Research Programme-Atrial Fibrillation). 2015, 1: 326-334.","journal-title":"JACC Clin Electrophysiol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1378\/chest.10-0134","article-title":"A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey","volume":"138","author":"R Pisters","year":"2010","unstructured":"R Pisters. A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey. 2010, 138: 1093-100.","journal-title":"Chest"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"3258","DOI":"10.1093\/eurheartj\/ehv476","article-title":"The ORBIT bleeding score: a simple bedside score to assess bleeding risk in atrial fibrillation","volume":"36","author":"EC O'Brien","year":"2015","unstructured":"EC O'Brien. The ORBIT bleeding score: a simple bedside score to assess bleeding risk in atrial fibrillation. 2015, 36: 3258-3264.","journal-title":"Eur Heart J"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.jacc.2011.03.031","article-title":"A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study","volume":"58","author":"MC Fang","year":"2011","unstructured":"MC Fang. A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study. 2011, 58: 395-401.","journal-title":"J Am Coll Cardiol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"e006212","DOI":"10.1161\/CIRCOUTCOMES.119.006212","article-title":"Net clinical benefit of oral anticoagulation among older adults with atrial fibrillation","volume":"12","author":"SJ Shah","year":"2019","unstructured":"SJ Shah. Net clinical benefit of oral anticoagulation among older adults with atrial fibrillation. 2019, 12: e006212.","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1111\/j.1538-7836.2005.01204.x","article-title":"Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients","volume":"3","author":"S Schulman","year":"2005","unstructured":"S Schulman. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients. 2005, 3: 692-694.","journal-title":"J Thromb Haemost"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"2422","DOI":"10.1093\/eurheartj\/ehi505","article-title":"Atrial fibrillation management: a prospective survey in ESC member countries: the Euro Heart Survey on Atrial Fibrillation","volume":"26","author":"R Nieuwlaat","year":"2005","unstructured":"R Nieuwlaat. Atrial fibrillation management: a prospective survey in ESC member countries: the Euro Heart Survey on Atrial Fibrillation. 2005, 26: 2422-2434.","journal-title":"Eur Heart J"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1002\/clc.22435","article-title":"The HAS-BLED score for predicting major bleeding risk in anticoagulated patients with atrial fibrillation: a systematic review and meta-analysis","volume":"38","author":"W Zhu","year":"2015","unstructured":"W Zhu. The HAS-BLED score for predicting major bleeding risk in anticoagulated patients with atrial fibrillation: a systematic review and meta-analysis. 2015, 38: 555-561.","journal-title":"Clin Cardiol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.jacc.2012.06.019","article-title":"Performance of the HEMORR(2)HAGES, ATRIA, and HAS-BLED bleeding risk-prediction scores in patients with atrial fibrillation undergoing anticoagulation: the AMADEUS (evaluating the use of SR34006 compared to warfarin or acenocoumarol in patients with atrial fibrillation) study","volume":"60","author":"S Apostolakis","year":"2012","unstructured":"S Apostolakis. Performance of the HEMORR(2)HAGES, ATRIA, and HAS-BLED bleeding risk-prediction scores in patients with atrial fibrillation undergoing anticoagulation: the AMADEUS (evaluating the use of SR34006 compared to warfarin or acenocoumarol in patients with atrial fibrillation) study. 2012, 60: 861-867.","journal-title":"J Am Coll Cardiol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1056\/NEJMoa1009638","article-title":"Rivaroxaban versus warfarin in nonvalvular atrial fibrillation","volume":"365","author":"MR Patel","year":"2011","unstructured":"MR Patel. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. 2011, 365: 883-891.","journal-title":"N Engl J Med"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"757087","DOI":"10.3389\/fcvm.2021.757087","article-title":"Diagnostic accuracy of the HAS-BLED bleeding score in VKA- or DOAC-treated patients with atrial fibrillation: a systematic review and meta-analysis","volume":"8","author":"X Gao","year":"2021","unstructured":"X Gao. Diagnostic accuracy of the HAS-BLED bleeding score in VKA- or DOAC-treated patients with atrial fibrillation: a systematic review and meta-analysis. 2021, 8: 757087.","journal-title":"Front Cardiovasc Med"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"19","DOI":"10.2217\/fca-2020-0014","article-title":"GARFIELD-AF: a worldwide prospective registry of patients with atrial fibrillation at risk of stroke","volume":"17","author":"JP Bassand","year":"2021","unstructured":"JP Bassand. GARFIELD-AF: a worldwide prospective registry of patients with atrial fibrillation at risk of stroke. 2021, 17: 19-38.","journal-title":"Future Cardiol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2014.11.046","author":"","unstructured":"","journal-title":"null"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1016\/S0140-6736(13)62343-0","article-title":"Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials","volume":"383","author":"CT Ruff","year":"2014","unstructured":"CT Ruff. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials. 2014, 383: 955-962.","journal-title":"Lancet"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1007\/s10557-020-06981-3","article-title":"Anticoagulants for stroke prevention in atrial fibrillation in elderly patients","volume":"34","author":"A Sch\u00e4fer","year":"2020","unstructured":"A Sch\u00e4fer. Anticoagulants for stroke prevention in atrial fibrillation in elderly patients. 2020, 34: 555-568.","journal-title":"Cardiovasc Drugs Ther"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1056\/NEJMoa1817083","article-title":"Antithrombotic therapy after acute coronary syndrome or PCI in atrial fibrillation","volume":"380","author":"RD Lopes","year":"2019","unstructured":"RD Lopes. Antithrombotic therapy after acute coronary syndrome or PCI in atrial fibrillation. 2019, 380: 1509-1524.","journal-title":"N Engl J Med"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.ejim.2017.03.012","article-title":"Oral anticoagulant therapy for older patients with atrial fibrillation: a review of current evidence","volume":"41","author":"M Bo","year":"2017","unstructured":"M Bo. Oral anticoagulant therapy for older patients with atrial fibrillation: a review of current evidence. 2017, 41: 18-27.","journal-title":"Eur J Intern Med"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1111\/jth.12352","article-title":"Clinical performance of bleeding risk scores for predicting major and clinically relevant non-major bleeding events in patients receiving warfarin","volume":"11","author":"S Burgess","year":"2013","unstructured":"S Burgess. Clinical performance of bleeding risk scores for predicting major and clinically relevant non-major bleeding events in patients receiving warfarin. 2013, 11: 1647-1654.","journal-title":"J Thromb Haemost"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.amjopharm.2008.03.005","article-title":"Risk factors for bleeding during anticoagulation of atrial fibrillation in older and younger patients in clinical practice","volume":"6","author":"AH Abdelhafiz","year":"2008","unstructured":"AH Abdelhafiz. Risk factors for bleeding during anticoagulation of atrial fibrillation in older and younger patients in clinical practice. 2008, 6: 1-11.","journal-title":"Am J Geriatr Pharmacother"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/j.rec.2019.10.025","article-title":"Impact of anticoagulation in patients with dementia and atrial fibrillation. Results of the CardioCHUVI-FA registry","volume":"73","author":"Paz R Cobas","year":"2020","unstructured":"Paz R Cobas. Impact of anticoagulation in patients with dementia and atrial fibrillation. Results of the CardioCHUVI-FA registry. 2020, 73: 877-884.","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.ijcard.2020.11.023","article-title":"Incidence, predictors of bleeding and prognosis of bleeding in anticoagulated nonagenarian patients with atrial fibrillation","volume":"327","author":"P Dom\u00ednguez-Erquicia","year":"2021","unstructured":"P Dom\u00ednguez-Erquicia. Incidence, predictors of bleeding and prognosis of bleeding in anticoagulated nonagenarian patients with atrial fibrillation. 2021, 327: 217-222.","journal-title":"Int J Cardiol"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"101652","DOI":"10.1016\/j.arr.2022.101652","article-title":"Frailty prevalence and impact on outcomes in patients with atrial fibrillation: A systematic review and meta-analysis of 1, 187, 000 patients","volume":"79","author":"M Proietti","year":"2022","unstructured":"M Proietti. Frailty prevalence and impact on outcomes in patients with atrial fibrillation: A systematic review and meta-analysis of 1, 187, 000 patients. 2022, 79: 101652.","journal-title":"Ageing Res Rev"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1253\/circj.CJ-20-0373","article-title":"Impact of frailty on bleeding events related to anticoagulation therapy in patients with atrial fibrillation","volume":"85","author":"M Ohta","year":"2021","unstructured":"M Ohta. Impact of frailty on bleeding events related to anticoagulation therapy in patients with atrial fibrillation. 2021, 85: 235-242.","journal-title":"Circ J"}],"container-title":["Journal of Geriatric Cardiology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T03:26:53Z","timestamp":1697167613000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.sciopen.com\/article\/10.26599\/1671-5411.2023.09.002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":23,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9]]}},"URL":"https:\/\/doi.org\/10.26599\/1671-5411.2023.09.002","relation":{},"ISSN":["1671-5411"],"issn-type":[{"value":"1671-5411","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]}}}